Pierachille Santus to Italy
This is a "connection" page, showing publications Pierachille Santus has written about Italy.
Connection Strength
0.190
-
Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study. Respir Med. 2021 03; 178:106323.
Score: 0.039
-
Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study. BMJ Open. 2020 10 10; 10(10):e043651.
Score: 0.038
-
Masks use and facial dermatitis during COVID-19 outbreak: is there a difference between CE and non-CE approved masks? Multi-center, real-life data from a large Italian cohort. Ital J Dermatol Venerol. 2021 Apr; 156(2):220-225.
Score: 0.010
-
Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics. Dermatol Ther. 2021 Mar; 34(2):e14823.
Score: 0.010
-
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy. Respir Med. 2020 12; 175:106204.
Score: 0.010
-
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J. 2020 10; 56(4).
Score: 0.009
-
Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches. Eur Respir J. 2020 05; 55(5).
Score: 0.009
-
Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020; 99(6):493-499.
Score: 0.009
-
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul; 26(7):880-894.
Score: 0.009
-
Early management of COPD: where are we now and where do we go from here? A Delphi consensus project. Int J Chron Obstruct Pulmon Dis. 2019; 14:353-360.
Score: 0.008
-
Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2019; 14:1-11.
Score: 0.008
-
Factors reducing omalizumab response in severe asthma. Eur J Intern Med. 2018 06; 52:78-85.
Score: 0.008
-
Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study. NPJ Prim Care Respir Med. 2017 Sep 07; 27(1):51.
Score: 0.008
-
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey. Pulm Pharmacol Ther. 2017 06; 44:83-87.
Score: 0.007
-
Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy. Respir Med. 2017 04; 125:8-11.
Score: 0.007